Psychedelics – reasons for caution: Stacy Fischer, Brian Anderson, Theora Cimino
GeriPal
MARCH 9, 2023
FDA is considering approval, shifting away from Schedule I restrictions, paving the way for use in clinical practice. It’s broader than just psychedelic assisted psychotherapy because there’s non-psychotherapists often involved, and it’s different from what we do in conventional mental health.
91 
Let's personalize your content